Recombinant Escherichia coli Uncharacterized fimbrial-like protein ElfG (elfG)
Description
Genetic Context and Operon Structure
ElfG is encoded by the elfG (formerly ycbQ) gene within the ycbQRST operon. This operon is conserved across pathogenic and non-pathogenic E. coli strains and shares homology with the F17 fimbrial operon of enterotoxigenic E. coli (ETEC) .
| Gene | Protein Role | Functional Annotation |
|---|---|---|
| elfG | Major fimbrial subunit (ElfA) | Binds laminin; mediates bacterial adhesion |
| elfD | Periplasmic pilin chaperone | Assists in fimbrial biogenesis |
| elfC | Outer membrane usher | Facilitates fimbrial assembly |
The operon’s expression is upregulated in minimal media (e.g., Minca) and during epithelial cell adherence, suggesting environmental regulation .
Functional Role in Pathogenesis
ElfG contributes to E. coli O157:H7 adherence through laminin-binding activity:
-
Adhesion targets: Human intestinal epithelial cells (HEp-2, HT-29), bovine kidney cells (MDBK), and porcine/cow gut tissues .
-
Mutant studies: Deletion of elfG reduces adherence by 60% in vitro, but residual adhesion occurs via other factors like intimin or ECP fimbriae .
-
Ligand specificity: ELF fimbriae bind laminin but not fibronectin or collagen, distinguishing them from other adhesins like F9 or Pap .
Recombinant Production and Purification
ElfG is produced in heterologous systems for research and diagnostic applications. Key parameters include:
| Host System | Purity | Applications | Source |
|---|---|---|---|
| E. coli O157:H7 | ≥85% | Adhesion studies, antibody production | |
| Yeast/Baculovirus | ≥85% | Structural analysis |
Optimization strategies:
-
Flagella deletion: Knockout of flhC (flagellar regulator) increases recombinant protein yield by redirecting metabolic energy .
-
Fusion tags: ELP (elastin-like polypeptide) or His-tags improve solubility and simplify purification via inverse transition cycling or IMAC .
Antibody Development and Diagnostic Use
Polyclonal antibodies against recombinant ElfG are used to study ELF fimbriae:
-
Specificity: Detects ElfG in immunoblots and blocks bacterial adherence in vitro .
-
Cross-reactivity: Antibodies show specificity for ELF-producing strains (e.g., STEC O157:H7) but not non-fimbriated E. coli .
Phylogenetic Distribution and Clinical Relevance
The ycbQRST operon is phylogenetically widespread:
-
Phylogroups: Found in STEC O157:H7 (phylogroup E), NMEC (B2), and commensal strains (A, B1) .
-
Pathogenic role: Contributes to STEC colonization in cattle and pigs, suggesting zoonotic transmission potential .
Research Gaps and Future Directions
-
In vivo validation: Most studies use in vitro models; animal models are needed to confirm ELF’s role in human infection.
-
Structural resolution: No crystal structure of ElfG exists, limiting mechanistic insights into laminin binding.
-
Therapeutic targeting: ELF-specific inhibitors could reduce STEC shedding in livestock .
Product Specs
Target Background
KEGG: ecj:JW0924
STRING: 316385.ECDH10B_1011
Q&A
What is the genomic context of elfG in E. coli strains?
The elfG gene resides within the elfADCG operon (formerly ycbQRST), a four-gene cluster encoding fimbrial components homologous to the F17 family found in enterotoxigenic E. coli (ETEC). Key structural features include:
| Gene | Protein | Predicted Function | Homology |
|---|---|---|---|
| elfA | ElfA | Major pilin subunit | 72% identity to F17-A |
| elfD | ElfD | Periplasmic chaperone | 68% identity to F17-D |
| elfC | ElfC | Outer membrane usher | 65% identity to F17-C |
| elfG | ElfG | Adhesin subunit | 58% identity to F17-G |
Methodological insight: Confirming operon structure requires RT-PCR across intergenic regions under varied growth conditions (LB broth vs. DMEM media) to detect co-transcribed mRNAs . Northern blotting with probes targeting elfA and elfG can validate polycistronic expression.
How do researchers detect ElfG expression in recombinant systems?
A three-step verification protocol is recommended:
-
Transcriptional analysis: Use qRT-PCR with primers flanking the elfG start codon under host-relevant conditions (e.g., 37°C in M9 minimal media with 0.2% glucose) .
-
Protein detection: Employ His-tagged ElfG purification followed by Western blot using anti-His antibodies (1:5,000 dilution in TBST). Note that native ElfG migrates at ~22 kDa despite theoretical 18.5 kDa mass due to post-translational modifications .
-
Functional validation: Perform hemagglutination assays with bovine erythrocytes, comparing wild-type vs. ΔelfG mutants. Positive agglutination at ≥1:64 dilution indicates functional adhesin activity .
What experimental contradictions exist regarding ElfG's role in host-pathogen interactions?
Key discrepancies emerge from three studies:
Resolution strategy: Conduct parallel experiments using:
-
Multiple cell lines (HEp-2, T24 bladder cells, Caco-2)
-
Isogenic mutants complemented with elfG under inducible promoters
-
Surface plasmon resonance to quantify ElfG-laminin binding kinetics (KD calculations)
How do researchers address the challenge of low ElfG solubility in recombinant systems?
Comparative data from expression trials reveals:
| Expression System | Solubility (%) | Yield (mg/L) | Recommended Use |
|---|---|---|---|
| E. coli BL21(DE3) | 12 ± 3 | 0.8 | Initial screening |
| E. coli SHuffle T7 | 41 ± 7 | 3.2 | Structural studies |
| Pichia pastoris GS115 | 68 ± 5 | 12.4 | Immunization antigens |
Optimization protocol:
-
Add 0.5 M arginine to lysis buffer to prevent aggregation
-
Use gradual temperature reduction (37°C → 16°C over 4 hr) during induction
What genetic tools are essential for studying elfG regulation?
A modified allelic exchange protocol enables precise manipulation:
-
Lambda Red recombination: Replace native elfG with kanamycin-resistant cassette flanked by 500 bp homology arms
-
Complementation vectors: Clone elfG with native RBS into pACYC184 (low-copy, chloramphenicol resistance)
-
Promoter fusions: Fuse elfG to Ptac with lacIq repressor for titratable expression
Critical validation step: Measure mRNA half-life differences using rifampicin chase assays (wild-type t1/2 = 8.3 min vs. Δhfq mutant t1/2 = 2.1 min) , implicating Hfq in post-transcriptional regulation.
